Completed PHASE4 INTERVENTIONAL NCT00171275

Fluvastatin in the Therapy of Acute Coronary Syndrome

Sponsor: Ministry of Health, Czech Republic

Conditions Coronary Disease Myocardial Infarction

Interventions Fluvastatin

Updated 6 times since 2017 Last updated: Jul 15, 2010 Started: Nov 30, 2003 Primary completion: Feb 28, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00171275, this PHASE4 trial focuses on Coronary Disease and Myocardial Infarction and remains completed. Sponsored by Ministry of Health, Czech Republic, it has been updated 6 times since 2003, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Nov 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ministry of Health, Czech Republic
Novartis

Data source: Novartis

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Prague, Czechia